CD4 and irritable bowel syndrome: Mucosal CD4+ T cells and mast cells from IBS patients are known to stimulate visceral nociceptive sensory neurons, suggesting that activation of mucosal immune cells in IBS patients leads to visceral hypersensitivity and altered colon motility.